Phase Rx Inc

Omeros Corporation is a leading biopharmaceutical company based in Seattle, WA. With a focus on innovative and cutting-edge science, their world-class team has achieved scientific breakthroughs that have led to the development of wholly new classes of therapeutics, benefiting patients with challenging diseases and disorders. Their deep and diverse pipeline of small-molecule and protein therapeutics includes first-in-class drugs with new mechanisms of action, targeting previously untapped receptors and enzymes. The Omeros team is known for being exceptionally talented, passionate, collaborative, and diverse. They are committed to hiring smart, creative, and hard-working individuals from around the world who want to make a meaningful impact in the biopharmaceutical industry. Together, they strive to provide hope to patients and their families by delivering better outcomes and life-saving therapies.Generated from the website

Luminex Corporation, based in Seattle, is a leading developer, manufacturer, and marketer of innovative biological testing technologies. Specializing in the clinical diagnostic and life science industries, Luminex Corporation is dedicated to advancing healthcare through cutting-edge solutions. Generated from their website's infomation

TwinStrand Biosciences Inc, based in Seattle, WA, is a leading biotechnology company specializing in high-resolution DNA sequencing technology. Their flagship product, TwinStrand Duplex Sequencing, offers a revolutionary approach to next-generation sequencing, reducing error rates and revealing hidden data by independently tracking both strands of individual DNA molecules. With applications in measurable residual disease detection, mutation signatures, and variant identification, TwinStrand Duplex Sequencing provides researchers with unparalleled accuracy and resolution beyond standard NGS methods. Through a combination of proprietary biochemistry and cloud-based informatics, TwinStrand Biosciences is at the forefront of advancing mutagenesis testing and genomic research. Their technology has been validated in collaboration with renowned institutions such as Health Canada, demonstrating its potential to overcome limitations in current mutagenicity assays and provide novel insights into the mutagenic mode of action. With a commitment to scientific collaboration and innovation, TwinStrand Biosciences is revolutionizing the field of DNA sequencing and empowering researchers to unlock the full potential of genetic analysis.Generated from the website